- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04018846
The Future of Revascularization Using a Bioprotec Graft (REVATEC)
September 8, 2023 updated by: Hôpital NOVO
The Future of the Revascularization Using a Bioprotec Graft
The main purpose of this study is the rate assessment of rescued limbs, one year after a BIOPROTEC vascular graft.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The BIOPROTEC grafts are controverted: they are useful in some cases, but they are known as frequently broken or thrombosed.
However they are always posed in a complicated situations, in a fragile patients who have ever had many of revascularizations or in an infectious state (which is supportive of the pseudoaneurysm and thrombosis) Despite the frequent use of this graft in France, the results have never been published.
Study Type
Observational
Enrollment (Actual)
46
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cergy-Pontoise, France
- Cntre Hospitalier René Dubos
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Grafted patient with a vascular BIOPROTEC graft in case of a Peripheral artery disease.
Description
Inclusion Criteria:
- ≥ Eighteen years old.
- Critical ischemia (Phase 4-6 of Rutherford): no saphenous equipment for the vascular reconstruction; at least one leg axis permeable.
Exclusion Criteria:
- Pregnant woman.
- Patient with an acute ischemia.
- Patient with an exceeded ischemia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Limb rescue rate one year after a BIOPROTEC graft
Time Frame: Two years
|
Usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
|
Two years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The revascularization permeability rate
Time Frame: Two years
|
Usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
|
Two years
|
The amputation rate
Time Frame: Two years
|
Usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
|
Two years
|
Infection resistance rate
Time Frame: Two years
|
Usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jean-Michel DAVAINE, Dr, Pitié Salpêtrière Vascular Surgery Service
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2018
Primary Completion (Actual)
October 7, 2021
Study Completion (Actual)
October 7, 2022
Study Registration Dates
First Submitted
July 10, 2019
First Submitted That Met QC Criteria
July 12, 2019
First Posted (Actual)
July 15, 2019
Study Record Updates
Last Update Posted (Actual)
September 11, 2023
Last Update Submitted That Met QC Criteria
September 8, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHRD0518
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Artery Disease
-
Janssen Scientific Affairs, LLCHCA Research Institute, LLCRecruitingCoronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedStructural Heart Disease | Obstructive Coronary Artery Disease | Obstructive Peripheral Artery DiseaseUnited States
-
Fangge DengRecruitingPeripheral Artery Disease (PAD)China
-
Fundacion para la Formacion e Investigacion Sanitarias...Not yet recruiting
-
Rontis Hellas SAPharmassist LtdActive, not recruitingPeripheral Artery Disease (PAD)Greece
-
Michael Lichtenberg, MDCompletedPeripheral Artery Disease (PAD)Germany
-
Helsinki University Central HospitalCompletedPeripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery RestenosisFinland
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
Seung-Whan Lee, M.D., Ph.D.Active, not recruitingCatheterization, Peripheral | Popliteal Artery | Angioplasty, Balloon | Femoral ArteryKorea, Republic of
-
Dartmouth-Hitchcock Medical CenterSociety for Vascular SurgeryCompletedPeripheral Artery Disease (PAD)United States
Clinical Trials on Revascularization using a BIOPROTEC Graft
-
NYU Langone HealthCompletedPeripheral Artery DiseaseUnited States
-
Ospedale San DonatoEmory University; University of PaviaCompletedCarotid Artery DiseasesItaly
-
Ain Shams Maternity HospitalRecruitingPelvic Organ Prolapse | Rectocele; FemaleEgypt
-
Lady Reading Hospital, PakistanCompletedHearing Loss,ConductivePakistan
-
phenox Inc.CompletedIschemia | Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Stroke, Ischemic | Stroke, AcuteUnited States, Germany
-
The University of Texas Health Science Center,...TerminatedIschemic Heart DiseaseUnited States
-
Cairo UniversityNot yet recruitingAlveolar Bone LossEgypt
-
Portuguese Society of CardiologyAbbott Medical DevicesUnknownCoronary Artery Disease | Valvular Heart DiseasePortugal
-
Arab American University (Palestine)Completed
-
Cairo UniversityNot yet recruiting